Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.

Ovcharenko D, Chitjian C, Kashkin A, Fanelli A, Ovcharenko V.

Cancer Biol Ther. 2019;20(9):1281-1289. doi: 10.1080/15384047.2019.1632131. Epub 2019 Jun 24.

PMID:
31234707
2.

[Combined treatment of complicated forms of angiodysplasias in conditions of a multimodality hospital].

Soroka VV, Borovsky IE, Khomchuk IA, Ovcharenko DV, Magamedov ID.

Angiol Sosud Khir. 2015;21(3):124-8. Russian.

PMID:
26355932
3.

MicroRNAs control transcription factor NF-kB (p65) expression in human ovarian cells.

Sirotkin AV, Alexa R, Kišová G, Harrath AH, Alwasel S, Ovcharenko D, Mlynček M.

Funct Integr Genomics. 2015 May;15(3):271-5. doi: 10.1007/s10142-014-0413-0. Epub 2014 Nov 18.

PMID:
25403593
4.

[Remote results of endovascular revascularization in patients with lower limb critical ischaemia (LLCI) kept on chronic haemodialysis].

Kaputin MIu, Platonov SA, Ovcharenko DV, Voronkov AA, Kiselev MA.

Angiol Sosud Khir. 2014;20(3):48-52. Russian.

PMID:
25267225
5.

[Case report of spine and spinal cord injury].

Sal'kov NN, Ovcharenko DV.

Zh Vopr Neirokhir Im N N Burdenko. 2014;78(3):49-52. English, Russian.

6.

Involvement of microRNA Mir15a in control of human ovarian granulosa cell proliferation, apoptosis, steroidogenesis, and response to FSH.

Sirotkin AV, Kisová G, Brenaut P, Ovcharenko D, Grossmann R, Mlyncek M.

Microrna. 2014;3(1):29-36.

PMID:
25069510
7.
8.

[Angiographic assessment of the incidence rate of atypical variants of the development of crural and plantar arteries].

Ovcharenko DV, Kaputin MIu, Voronkov AA, Platonov SA.

Angiol Sosud Khir. 2012;18(1):57-60. Russian.

PMID:
22836329
9.

Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.

Baoum A, Ovcharenko D, Berkland C.

Int J Pharm. 2012 May 1;427(1):134-42. doi: 10.1016/j.ijpharm.2011.08.012. Epub 2011 Aug 12.

PMID:
21856394
10.

miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.

Ovcharenko D, Stölzel F, Poitz D, Fierro F, Schaich M, Neubauer A, Kelnar K, Davison T, Müller-Tidow C, Thiede C, Bornhäuser M, Ehninger G, Brown D, Illmer T.

Exp Hematol. 2011 Oct;39(10):1030-1042.e7. doi: 10.1016/j.exphem.2011.07.008. Epub 2011 Jul 22.

PMID:
21784052
11.

MicroRNA29a regulates the expression of the nuclear oncogene Ski.

Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T, Neubauer A.

Blood. 2011 Aug 18;118(7):1899-902. doi: 10.1182/blood-2010-09-306258. Epub 2011 Jun 17.

12.
13.

[Transluminal balloon angioplasty as a method of choice in treatment of critical ischemia of lower extremities].

Kaputin MIu, Ovcharenko DV, Boĭtsova OV, Sidorov VN, Soroka VV, Dudanov IP.

Vestn Khir Im I I Grek. 2010;169(4):49-54. Russian.

PMID:
20973186
14.

Identification of microRNAs controlling human ovarian cell proliferation and apoptosis.

Sirotkin AV, Lauková M, Ovcharenko D, Brenaut P, Mlyncek M.

J Cell Physiol. 2010 Apr;223(1):49-56. doi: 10.1002/jcp.21999.

PMID:
20039279
15.

[Transluminal balloon angioplasty in treatment of lower limb critical ischaemia].

Kaputin MIu, Ovcharenko DV, Soroka VV, Borovskiĭ IE, Dudanov IP, Bregovskiĭ VB.

Angiol Sosud Khir. 2009;15(1):142-7. Russian.

PMID:
19791588
16.

Identification of protein kinases that control ovarian hormone release by selective siRNAs.

Sirotkin AV, Ovcharenko D, Mlyncek M.

J Mol Endocrinol. 2010 Jan;44(1):45-53. doi: 10.1677/JME-08-0179. Epub 2009 Aug 27.

PMID:
19713423
17.

Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen.

Sirotkin AV, Ovcharenko D, Grossmann R, Lauková M, Mlyncek M.

J Cell Physiol. 2009 May;219(2):415-20. doi: 10.1002/jcp.21689.

PMID:
19194990
18.

[Peripheral angioplasty in patients with lower limb critical ischaemia after operations of femoropopliteal bypass grafting].

Ovcharenko DV, Kaputin MIu, Platonov SA.

Angiol Sosud Khir. 2009;15(4):43-7. Russian.

PMID:
20394331
19.

Protein kinases controlling PCNA and p53 expression in human ovarian cells.

Sirotkin AV, Ovcharenko D, Benco A, Mlyncek M.

Funct Integr Genomics. 2009 May;9(2):185-95. doi: 10.1007/s10142-008-0102-y. Epub 2008 Dec 9.

PMID:
19067003
20.

Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.

Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D.

Cancer Res. 2007 Nov 15;67(22):10782-8.

21.

The let-7 microRNA represses cell proliferation pathways in human cells.

Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ.

Cancer Res. 2007 Aug 15;67(16):7713-22.

22.

Neutrophil gelatinase-associated lipocalin as a survival factor.

Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP.

Biochem J. 2005 Oct 15;391(Pt 2):441-8.

23.

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Loots GG, Kneissel M, Keller H, Baptist M, Chang J, Collette NM, Ovcharenko D, Plajzer-Frick I, Rubin EM.

Genome Res. 2005 Jul;15(7):928-35. Epub 2005 Jun 17.

24.

High-throughput RNAi screening in vitro: from cell lines to primary cells.

Ovcharenko D, Jarvis R, Hunicke-Smith S, Kelnar K, Brown D.

RNA. 2005 Jun;11(6):985-93.

25.

High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways.

Sachse C, Krausz E, Krönke A, Hannus M, Walsh A, Grabner A, Ovcharenko D, Dorris D, Trudel C, Sönnichsen B, Echeverri CJ.

Methods Enzymol. 2005;392:242-77.

PMID:
15644186
26.

Phylogenetic shadowing of primate sequences to find functional regions of the human genome.

Boffelli D, McAuliffe J, Ovcharenko D, Lewis KD, Ovcharenko I, Pachter L, Rubin EM.

Science. 2003 Feb 28;299(5611):1391-4.

Supplemental Content

Loading ...
Support Center